Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Current management and recent progress in desmoid tumors.
Cancer Treat Res Commun. 2022;31:100562. doi: 10.1016/j.ctarc.2022.100562. Epub 2022 Apr 16.
Cancer Treat Res Commun. 2022.
PMID: 35460976
Free article.
Review.
Desmoid tumors are rare soft tissue tumors that can have aggressive infiltrative growth and relapse locally. ...Systemic therapy options currently include hormonal agents, nonsteroidal anti-inflammatory drugs, tyrosine kinase inhibitors, and anthracycline-bas …
Desmoid tumors are rare soft tissue tumors that can have aggressive infiltrative growth and relapse locally. ...Systemic th …
Update on treatment of light chain amyloidosis.
Mahmood S, Palladini G, Sanchorawala V, Wechalekar A.
Mahmood S, et al.
Haematologica. 2014 Feb;99(2):209-21. doi: 10.3324/haematol.2013.087619.
Haematologica. 2014.
PMID: 24497558
Free PMC article.
Review.
Light chain amyloidosis is the most common type of amyloidosis as a consequence of protein misfolding of aggregates composed of amyloid fibrils. The clinical features are dependent on the organs involved, typically cardiac, renal, hepatic, peripheral and autonomic neuropat …
Light chain amyloidosis is the most common type of amyloidosis as a consequence of protein misfolding of aggregates composed of amyloid …
Item in Clipboard
Cite
Cite